Biopharma News : Biopharma and Pharma news from all around the world :
- CORRECTING and REPLACING Study Shows Guardant Reveal™ Blood-Only Liquid Biopsy Test Predicts Risk for Colorectal Cancer Recurrence with Industry-Leading Sensitivity
- Element Nutritional Sciences Announces Closing of $5 Million Bought Deal Private Placement
- AHF Files Federal Antitrust Lawsuit Against the PBM Prime Therapeutics
- BeiGene Announces China NMPA Approval of BRUKINSA® (Zanubrutinib) for the Treatment of Patients with Relapsed or Refractory Waldenström’s Macroglobulinemia
- CytRx Notes Orphazyme’s Regulatory Update from the FDA on Arimoclomol for Niemann-Pick Disease Type C
- Cybin to Present at the Emerging Growth Conference on June 23rd
- Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- IMV Announces Annual and Special Meeting of Shareholders Voting Results
- AHF Joins Coalition Demanding Rx Price Negotiation in ‘Build Back Better’ Law
- Horizon Therapeutics plc Announces Multiple Presentations on Neuromyelitis Optica Spectrum Disorder (NMOSD) at the 7th Congress of the European Academy of Neurology (EAN)
- H1 2021 Neuromyelitis Optica (Devic’s Syndrome) Global Clinical Trials Review – ResearchAndMarkets.com
- Global Antibiotics Active Pharmaceutical Ingredient (API) Market Forecast, Trend Analysis & Opportunity Assessment 2020-2030 – ResearchAndMarkets.com
- Chemotherapy-Induced Anemia Clinical Landscape Market Report 2021 – ResearchAndMarkets.com
- Insights on the Neurological Biomarkers for Alzheimers and Parkinsons Diseases Global Market to 2027 – Featuring AbaStar, Abbott Laboratories and Abiant Among Others – ResearchAndMarkets.com
- Bristol Myers Squibb Receives European Commission Approval for Onureg® (azacitidine tablets) as Frontline Oral Maintenance Therapy for Adults with Acute Myeloid Leukemia
- Healthy Transportation Foundation Partners with AscellaHealth to Offer Discount Rx Card for Professional Truck Drivers and Families
- Taro Annual Report on Form 20-F Available For Fiscal Year Ended March 31, 2021
- Reven Pharmaceuticals Reports a Promising Second Generation Formulation of Its Lead Anti-sepsis Drug Candidate Rejuveinix (RJX)
- PharmaCyte Biotech Announces Adjournment of Annual Meeting of Stockholders, Recording of Stockholder Meeting Available
- Iveric Bio to Present Zimura® GATHER2 Enrollment and Retention Updates and New GATHER1 Post-Hoc Analyses Today at its Dry Age-Related Macular Degeneration Virtual Symposium for Investors
- Moderna Reaffirms Commitment to Job Creation in Massachusetts
- Non-Alcoholic Steatohepatitis (NASH) Global Clinical Trials Review, H2, 2020 – ResearchAndMarkets.com
- Global Blood Cell Analyzer Market Report 2021: Market to Reach $2.1 Billion by 2027 – Semi-automated Biochemistry Analyzers to Account for $539.5 Million – ResearchAndMarkets.com
- Global Hematology Partnering Deal Trends, Players and Financials Report 2021 – ResearchAndMarkets.com
- United States IVD Market Predicted to Reach $37 Billion by 2026 Driven by a High Prevalence of Chronic Disease – ResearchAndMarkets.com
- Lab-on-a-Chip and Microfluidics Europe Online Conference 2021 (June 28-30, 2021) – ResearchAndMarkets.com
- Ambrx Announces Pricing of Initial Public Offering
- Cyteir Therapeutics Announces Pricing of Initial Public Offering
- Eisai and Bristol Myers Squibb Enter Into Global Strategic Collaboration for Eisai’s MORAb-202 Antibody Drug Conjugate
- ADEA Applauds Senate Bill to Permanently Allow Qualified Students to Vaccinate
Biotech – Biopharma News!
- APONTIS PHARMA AG: Initial studies confirm that the share has a price potential of between 77% and 135%
- Antibacterial silver coating technology: aap’s silver coated implant used for first time in patient
- Rapid Nutrition PLC: Admission to trading on the Euronext Growth Paris Market
- Heidelberg Pharma Announces Participation at Various Conferences
- Kuros Biosciences to present at upcoming U.S. spine conferences
- MorphoSys Commences Cash Tender Offer for All Outstanding Shares of Constellation Pharmaceuticals
- Relief Therapeutics Reports that Collaboration Partner, NRx Pharmaceuticals, has Announced Additional Results from the Aviptadil U.S. Expanded Access Protocol for Patients with Critical COVID-19
- Xlife Sciences AG: curasan AG and Xlife Sciences AG cooperate in the field of regenerative medicine
- Heidelberg Pharma AG Raises EUR 20 Million From Private Placement
- Heidelberg Pharma AG to Raise Capital in a Private Placement
- PharmaSGP Group acquires OTC brand portfolio (Baldriparan, Formigran, Spalt and Kamol) from GSK
- Evotec SE virtual Annual General Meeting 2021 approves all proposed agenda items
- Geratherm Medical AG: Subsidiary apoplex medical and Telekom: Together against stroke
- Cannovum AG enters cannabis market segment Dronabinol
- Evotec launches ‘PRROTECT’, a pre-competitive initiative to be better prepared for future pandemics
- Zur Rose Group strengthens Group Management: Madhu Nutakki to become Chief Technology Officer
- Epigenomics AG plans to issue mandatory convertible bond in the amount of up to EUR 18.15 million
- MediClin AG: Dr. Joachim Ramming becomes the new CEO of MEDICLIN
- APONTIS PHARMA AG: Post-Stabilisation disclosure – Partial exercise of the Greenshoe Option
- Medios AG holds successful 2021 Annual General Meeting – Focus on Corporate Governance
- SYNLAB to continue providing COVID-19 testing at UEFA competition matches and UEFA EURO 2020
- Xlife Sciences AG: Breakthrough in Drug Development
- RHÖN-KLINIKUM Aktiengesellschaft: 33rd Ordinary Annual General Meeting of RHÖN-KLINIKUM AG
- Rapid Nutrition PLC: Rapid Nutrition Helps Health-Focused Consumers Continue to Flatten the Curve with SystemLS Wellness Brand
- BRAIN Biotech AG: BRAIN actively supports the UN Global Compact
- Eckert & Ziegler: Affiliates Receives Additional NIAID Funding to Advance Pharmaceutical Development
- Polyphor Hosting Key Opinion Leader Roundtable on Covid-19: The Need for Novel Therapies for Severe Infections and the Potential Role of Balixafortide, a Selective CXCR4 Antagonist
- Abivax releases the results of its June 4, 2021 ordinary annual and extraordinary general meeting
- MagForce AG Supports World Brain Tumor Day and Informs about Various Patient Events to Raise Awareness for One of the Deadliest Oncological Indications
- DEFENCE THERAPEUTICS RETAINS THE HUS COMPREHENSIVE CANCER CENTER TO OPTIMIZE ITS ACCUM-T-DM1 ADC THERAPEUTIC
- Disabilities Special Needs Dentist Duncanville Forth Worth TX Updates Services
- Invisalign Midtown East NY Clear Aligner Therapy For Teeth Straightening Updated
- Biophytis announces new convertible bond financing for up to €32 million with Atlas and drawing of 2 tranches under the 2020 Atlas Contract for €6 million
- Ocugen Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Baudax Bio Announces Special Meeting of Shareholders to Vote on Proposed Increase in Number of Authorized Shares of Common Stock
- Tarsus Pharmaceuticals, Inc. Schedules Conference Call and Webcast to Announce Saturn-1 Phase 2b/3 Pivotal Trial Results for TP-03 for the Treatment of Demodex Blepharitis
- TG Therapeutics Announces Presentation of Data from the ULTIMATE I & II Phase 3 Trials of Ublituximab in Multiple Sclerosis at 7th Congress of the European Academy of Neurology
- New Zolgensma data demonstrate age-appropriate development when used presymptomatically and rapid, clinically meaningful efficacy in symptomatic children, even those with severe SMA at baseline
- RAPT Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
- HUTCHMED Announces NMPA Approval of Surufatinib (Sulanda® in China) for Advanced Pancreatic Neuroendocrine Tumors
- Teligent, Inc. Announces Adjournment of Annual Meeting of Stockholders
- Evergreen Therapeutics, Inc. Announces Agreement with ICON plc to Conduct Phase II Clinical Trial for COVID-19 Drug Candidate
- Largest Real-World Registry Supporting Neovasc Reducer™ Safety and Efficacy Outcomes Published in International Journal of Cardiology
- G1 Therapeutics Announces Addition of Alicia Secor to Board of Directors
- RESOLUTIONS of the Extraordinary General Meeting Of Shareholders of JSC “Olainfarm” held on June 18th, 2021
- Exagen Elects Frank Stokes to Board of Directors
- Predictmedix Inc. Files Registration Statement on Form 20-F With the SEC
- News about JSC Olainfarm Supervisory Council and Management Board
- BioNTech Announces First Patient Dosed in Phase 2 Clinical Trial of mRNA-based BNT111 in Patients with Advanced Melanoma
- Core One Labs Retains Canada’s Highest-Ranked IP Law Firm to Assist With Patent Filings
- Orphazyme provides regulatory update from FDA on arimoclomol for Niemann-Pick disease type C
- atai Life Sciences Announces Pricing of Upsized Initial Public Offering
- Codex DNA Announces Pricing of Initial Public Offering
- Femasys Inc. Announces Pricing of Initial Public Offering
- First Patient Dosed in Phase II Basket Trial of Taletrectinib for Solid Tumors with NTRK Fusion
- HUTCHMED Launches Hong Kong Initial Public Offering
- Century Therapeutics Announces Pricing of Initial Public Offering
- IBEX Reports Results for the Third Quarter and the Nine Months Ended April 30, 2021
- Athira Pharma Chief Operating Officer, Mark Litton, Assumes Day-to-Day Leadership Responsibilities of Company
- Codexis Raises 2021 Guidance Following Receipt of Significant New Order for a Proprietary Enzyme Product
.
Biotech – Biopharma News!
Every day, Biotech 365 brings you information about Biotech Companies, Biopharma News, Biotech Tools, Bioinformatic tips and BioMarketplace ! To receive weekly notifications about Biopharma News and the last articles added to Biotech 365, please register to our Newsletter. And please Follow Biotech 365 on Twitter ( https://twitter.com/Biotech365 ) and LinkedIn (www.linkedin.com/company/biotech-365 ) … thanks !!!
Biotech 365 is an independent website, sharing information and news about Biotech Companies, Biotechnology, Biopharma News and Pharma News. If you want to contribute, you’re welcome! Please do not hesitate to Contact us ! Thanks !!!
Lots of very interesting and promising Biopharma Companies emerge everyday around the world. Looking for new partners? For new suppliers or clients? Biotech-365.com will present you lots of Biotech companies from all around the world and keep you informed about the last Biopharma news ! Don’t lose your time searching for new Biotech or Biopharma partners! The most interesting ones are on Biotech-365.com !
You want to propose a Biotech Company, a Biotech Tool or a Bioinformatic software to be presented on Biotech-365.com? Please use our Contact page ! Interested in becoming our partner? Please Contact us ! Thanks !!! If you want to promote your Biotech company or Biopharma Company on our website, please check our Offers! Biotech 365 brings you every day the more interesting information about Biopharma News, Biotech Companies and Biotech Tools! Enjoy them with a good coffee and share with your teammates!
Biopharma News – Pharma News
Biotech 365 : daily news about Biotech and Biopharma
Sources for this page of Biopharma News : biopharma-reporter.com and worldpharmanews and pharmatimes.com and drugs.com and fiercepharma.com and scripintelligence.com and PR Newswire and Business Wire. Please visit all this very interesting websites ! Thanks !
Biopharma News – Pharma News
Biopharma News – Pharma News